Abiopharma

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

General Announcement::USE OF PROCEEDS FROM THE PLACEMENT

Arcutis Completes Enrollment in INTEGUMENT-INFANT Phase 2 Study Evaluating ZORYVE® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis

Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights

KORU Medical Systems to Participate in Upcoming Investor Conferences

Omnicell - Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial